We are enGeneers

DEEPLY FOCUSED ON PATIENT OUTCOMES AND BREAKING BARRIERS IN GENETIC MEDICINE

We are a team of passionate experts with extensive experience in drug development and commercialization across oncology, urology and several other therapeutic areas.

Seeking fearless people committed to patient needs. Let’s forge a new path in genetic medicine.

Join Us

Leadership

Ron Cooper

Chief Executive Officer & Director

Anthony T. Cheung, PhD

Co-Founder & Chief Scientific Officer

Matthew Boyd

Chief Regulatory Officer

Jill Buck

Chief Development Officer

Joan Connolly

Chief Technology Officer

Ryan Daws

Chief Financial Officer

Lee G. Giguere, JD

Chief Legal Officer & Secretary

William Grossman, MD, PhD

Interim Chief Medical Officer

Alex Nichols, PhD

Chief Strategy & Operations Officer

Tara Place

SVP, Human Resources

Amy Pott

Chief Global Commercialization Officer

Board of Directors

Richard Glickman, LLD

Chairman • Independent

Philip Astley-Sparke

Independent

Gerry Brunk, MBA

Independent

Ron Cooper

Chief Executive Officer

William Grossman, MD, PhD

Independent

Paul Hastings

Independent

Michael Heffernan, RPh

Independent

Wouter Joustra, MSc

Independent

Lota S. Zoth, CPA

Independent